A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients
- Authors
-
-
Joseph V. Pergolizzi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA 2Department of Anesthesiology, Georgetown University School of Medicine, Washington, D.C., USA 3Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA -
Gianpietro Zampogna
NEMA Research, Naples, Florida, USA -
Robert Taylor
NEMA Research, Naples, Florida, USA -
Marixa Guerrero
Medical Director of Instituto de Ortopedia Roosevelt, Bogota, Colombia -
Juan Quillermo Santacruz
Palliativist of Fundacion Santa fe, Bogota, Colombia -
Robert B. Raffa
Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
-
- Keywords:
- Cancer pain, malignant pain, opioid analgesia, opioids, undertreatment of cancer pain, assessment of cancer pain.
- Abstract
-
The fundamental approach to cancer patients with pain is to identify the pain sites, and describe, quantify, and categorize the pain by type at each site. There are many validated tools to serve the clinician in these efforts, particularly for pain assessment. Multimechanistic pain syndromes are common in cancer patients. Cancer patients may experience nociceptive pain. They may also experience neuropathic pain due to chemotherapy-induced or cancer-related nerve damage. Analgesic choices must be guided by the pain mechanisms, nature, and severity of the pain, comorbid conditions, and patient characteristics. Long-acting opioid analgesics or fixed-clock dosing can eliminate end-of-dose analgesic gaps. The potential for opioid abuse is an important public health challenge but one that should not undermine the appropriate treatment of moderate to severe cancer pain. Abuse-deterrent opioid formulations can be useful. Care is needed for special populations of cancer patients dealing with pain, such as geriatric, pediatric, or obese patients. While morphine has long been the gold standard of oral opioid products, recent clinical trials suggest that oral hydrocodone and oral oxycodone may offer advantages over oral morphine. Patient adherence is crucial for adequate analgesia and patient education can promote adherence and manage expectations.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 14-01-2016
- Issue
- Vol. 5 No. 1 (2016)
- Section
- Articles
How to Cite
Similar Articles
- Khosravi-Shahi Parham, Aparicio-Salcedo María Inmaculada, Alva-Bianchi Manuel, Arregui-Valles Marta, Morón-García Blanca Isabel, Tirado-Anula Victoria Clara, De Toro-Carmena María, Martínez-Delfrade Iñigo, González-del-Val Ricardo, Liver Abscesses in Cancer Patients Associated with Poor Prognosis: A Single Center Experience , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Indra Kanta Maitra, Sangita Bhattacharjee, Debnath Bhattacharyya, Tai-Hoon Kim, Samir Kumar Bandyopadhyay, Adaptive Edge Detection Technique Towards Features Extraction from Mammogram Images , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Sisir Nandi, Manish C. Bagchi, Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer , Journal of Cancer Research Updates: Vol. 11 (2022)
- Sung-Han Hsiao, Shi-Yu Luo, Ching-Ya Su, Wei-Cherng Tuo, Cheng-Ting Chiang, Yan-Qing Li, Yang-Hui Huang, Chung-Pu Wu, The Overexpression of ABCG2 Reduces the Efficacy of Volasertib (BI 6727) and GSK641364 in Human S1-M1-80 Colon Carcinoma Cells , Journal of Cancer Research Updates: Vol. 3 No. 2 (2014)
- Peng-Wei Zhang, Zhe-Sheng Chen, Zhi Shi, Targeting Snail1 by CRISPR/Cas9 System Inhibits the Proliferation and Migration of Human Gastric Cancer Cells , Journal of Cancer Research Updates: Vol. 12 (2023)
- Guanghui Yang, Honglu Zhang, Glenn D. Prestwich, Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Ciro Comparetto, Franco Borruto, Liquid Biopsy: A New, Non-Invasive Early Diagnostic and Prognostic Tool in Oncology , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Hua-Qing Chen, Yi-Si Li, Si-Chao Huang, Ya-Hua Lin, Qiu-Tong Tan, Shu-Ting Ao, Jun Xu, Shao-Hui Cai, The Clinical Efficacy and Safety of Paclitaxel in Adjuvant Therapy of Breast Cancer: A Systematic Review and Meta-Analysis , Journal of Cancer Research Updates: Vol. 4 No. 2 (2015): Special Issue - Natural Products for Cancer Prevention and Treatment
- Mario M. Soldevilla, Susana Inogés, Ascensión López-Díaz de Cerio, Fernando Pastor, Helena Villanueva, Maurizio Bendandi, Biological Efficacy of a Dendritic Cell-Based Vaccine in a Patient with Metastatic Colorectal Cancer , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Vito Lorusso, Ilaria Marech, Marianna Giampaglia, Andrea Tinelli, Vincenzo Emanuele Chiuri, Present and Emerging Targeted Therapy for Metastatic Breast Cancer , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)